|
Active substance |
Pirfenidon |
|
Holder |
Roche |
|
Status |
closed |
|
Indication |
Treatment of adult patients with unclassifiable interstitial lung disease (uILD) and who exit trial MA39189. |
|
Documents publics |
|
| Approbation amendment | |
|
Last update |
19/04/2024 |